Revolutionizing City Planning for Visual Wellness
Guangzhou has introduced the world’s first street-level digital map designed specifically for eye health protection. The innovative platform, launched June 6th, enables citizens to access optimized travel routes featuring wide vistas, lush greenery, and clean air through a dedicated mini-program.
Interdisciplinary Collaboration
Developed through a partnership between:
- Professor Lin Haotian’s team at Zhongshan Ophthalmic Center
- Professor Cheng Xiao’s group from Sun Yat-sen University’s School of Surveying and Mapping
- Integration of six academic disciplines including public health and AI
Science-Based Urban Eye Health
Research reveals critical environmental connections:
| Environmental Factor | Eye Health Impact |
|---|---|
| Green space coverage | 25% reduction in childhood myopia risk |
| Building height | Increased distant viewing opportunities |
| Air quality | Direct correlation with dry eye syndrome |
Five Key Evaluation Metrics
The system assesses streets using:
- Green vision rate (minimum 30% recommended)
- Sky visibility index
- Street enclosure ratio
- Average visible distance (target: >50m)
- Air pollution percentage
Smart Navigation Features
The dynamic platform offers:
- Real-time route optimization based on environmental sensors
- Personalized recommendations for different eye conditions
- Continuous data updates via satellite and ground monitoring
Privacy and Data Security
All data collection complies with China’s:
- Personal Information Protection Law
- Data Security Law
- Cybersecurity regulations
Future Applications
Planned developments include:
- Integration with urban planning departments
- Expansion to 10 additional Chinese cities by 2026
- School zone optimization features
“This transforms every commute into an opportunity for eye health,” said Professor Lin. “We’re setting new global standards for vision-conscious urban design.”
The mini-program is now available through Guangzhou’s municipal services platform, with plans for nationwide adoption pending further trials.
Related topics：
